Resource Roundup: Integrative Interventions for Preventing Alzheimer's Disease

Dr. David Perlmutter on the Key to Preventing Alzheimer’s Disease

Recently, the United States Food and Drug Administration (FDA) expedited the approval of two types of drugs aimed at addressing β-amyloid, the sticky protein widely recognized as the cause of Alzheimer’s. However, research suggests that decreasing β-amyloids is not the solution to preventing cognitive decline, said David Perlmutter, MD, FACN, ABIHM, at the Integrative Healthcare Symposium in New York City.

"We’re bombarded with the idea that the amyloid hypothesis of Alzheimer's disease is rock solid,” said Dr. Perlmutter, board-certified neurologist and author of Grain Brain, “despite the fact that some of the seminal work in 2006 was found to be fabricated and that the images used for some of the displays of the proteins were actually Photoshopped.”

To read more, click here.